JPRN-UMIN000001902已完成未知
Analysis of third-line H. pylori eradication therapy with sitafloxacin - Analysis of H. pylori eradication with sitafloxacin
Department of Gastroenterology, University of Tokyo0 个研究点目标入组 50 人开始时间: 2009年4月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •penicillin or quinolone allergy rabeprazole allergy severe liver or renal dysfunction pregnancy or suckling cases with unsuitable determined by doctors
研究者
相似试验
已完成
不适用
The study of H.pylori third line eradication therapy using VonoprazaHelicobacter pylori infectionJPRN-UMIN000024290ational Hospital Organization National Kochi Hospital gstroenterology10
已完成
3 期
The efficacy and safety of third line H. pylori eradication therapy with sitafloxacin, amoxicillin and PPIH. pylori-positve patients after the 2nd line eradication failureJPRN-UMIN000013194Keio University School of Medicine100
已完成
3 期
The efficacy and safety of third line H. pylori eradication therapy with sitafloxacin, metronidazole and PPIH. pylori-positve patients after the 2nd line eradication failure or penicillin-allergic patientsJPRN-UMIN000013195Keio University School of Medicine100
已完成
不适用
Evaluation of the efficasy of H. pylori eradication therapies using different PPI.gastritis caused by H. pylori infectionJPRN-UMIN000014366Hirosaki University Graduate School of Medicine200
Unknown
不适用
Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori InfectionH Pylori Infection EradicationAntibiotics Therapeutic StrategiesH Pylori EradicationNCT02576236Assistance Publique - Hôpitaux de Paris2,500